TP53 and cancer: The molecular pathway by which p53 acts to prevent tumour development can be disrupted in cancers by multiple mechanisms, not only by sequence mutation of the gene itself [for example [25] but the experiment described here provides genetic confirmation that disruption of the broader p53 pathway is unlikely to be important in these endocrine tumour types.